{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:01:31Z","timestamp":1768413691597,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>miRNAs have been extensively studied in pathological conditions, including viral infections, such as those provoked by HIV-1. Several cellular and circulating miRNAs are altered during HIV-1 infection, with either beneficial effects on host defenses or enhanced virus infectivity. Blood samples were collected in sterile EDTA tubes and plasma was separated and stored, as were PBMCs. RNA was isolated and reverse-transcribed. Finally, the miRNA gene expression profile was assessed using TaqMan Array Human microRNA Card A v2.0. A comprehensive statistical analysis was performed on the results obtained. This is the first study on miRNAs in HIV-1 paediatric patients, and a miRNA profile differentiating patients starting combination antiretroviral therapy (cART) at different times after HIV-1 diagnosis was established. Thirty-four miRNAs were observed to have different expression levels between the control group and the cART group. The data indicates the need to start cART as soon as possible after the establishment of HIV-1 infection to assure the best outcome possible. Finally, the selected 34 miRNAs may be used as biomarkers for prognosis and assessing therapy effectiveness. However, more research must be conducted to establish adequate quantitative correlations.<\/jats:p>","DOI":"10.1038\/s41598-021-03020-5","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T11:06:05Z","timestamp":1638788765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Establishment of a miRNA profile in paediatric HIV-1 patients and its potential as a biomarker for effectiveness of the combined antiretroviral therapy"],"prefix":"10.1038","volume":"11","author":[{"given":"Irene","family":"Consuegra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samanta","family":"Gasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Serram\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"3020_CR1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew, R. W. & Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642\u2013655 (2009).","journal-title":"Cell"},{"key":"3020_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature07755","volume":"457","author":"M Jinek","year":"2009","unstructured":"Jinek, M. & Doudna, J. A. A three-dimensional view of the molecular machinery of RNA interference. Nature 457, 405\u2013412 (2009).","journal-title":"Nature"},{"key":"3020_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tree.2008.06.005","volume":"23","author":"SA Shabalina","year":"2008","unstructured":"Shabalina, S. A. & Koonin, E. V. Origins and evolution of eukaryotic RNA interference. Trends Ecol. Evol. 23, 578\u2013587 (2008).","journal-title":"Trends Ecol. Evol."},{"key":"3020_CR4","doi-asserted-by":"crossref","unstructured":"Catalanotto, C., Cogoni, C., Zardo, G. MicroRNA in control of gene expression: An overview of nuclear functions. Int. J. Mol. Sci. 17 (2016).","DOI":"10.3390\/ijms17101712"},{"key":"3020_CR5","doi-asserted-by":"publisher","first-page":"970607","DOI":"10.1155\/2014\/970607","volume":"2014","author":"A Valinezhad Orang","year":"2014","unstructured":"Valinezhad Orang, A., Safaralizadeh, R. & Kazemzadeh-Bavili, M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int. J. Genomics 2014, 970607 (2014).","journal-title":"Int. J. Genomics"},{"key":"3020_CR6","doi-asserted-by":"crossref","unstructured":"Rusk, N. 2008 When microRNAs activate translation. Nat. Methods 122\u2013123.","DOI":"10.1038\/nmeth0208-122a"},{"key":"3020_CR7","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1126\/science.1149460","volume":"318","author":"S Vasudevan","year":"2007","unstructured":"Vasudevan, S., Tong, Y. & Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931\u20131934 (2007).","journal-title":"Science"},{"key":"3020_CR8","doi-asserted-by":"crossref","unstructured":"Balasubramaniam, M., Pandhare, J., Dash, C. Are microRNAs important players in HIV-1 infection? An update. Viruses 10 (2018).","DOI":"10.3390\/v10030110"},{"key":"3020_CR9","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.3389\/fimmu.2019.03079","volume":"10","author":"R Mishra","year":"2019","unstructured":"Mishra, R., Kumar, A., Ingle, H. & Kumar, H. The interplay between viral-derived miRNAs and host immunity during infection. Front. Immunol. 10, 3079 (2019).","journal-title":"Front. Immunol."},{"key":"3020_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/B978-0-12-415795-8.00002-7","volume":"102","author":"AP Roberts","year":"2011","unstructured":"Roberts, A. P., Lewis, A. P. & Jopling, C. L. The role of microRNAs in viral infection. Prog. Mol. Biol. Transl. Sci. 102, 101\u2013139 (2011).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"3020_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fmicb.2017.00824","volume":"8","author":"P Bruscella","year":"2017","unstructured":"Bruscella, P. et al. Viruses and miRNAs: More friends than foes. Front. Microbiol. 8, 824 (2017).","journal-title":"Front. Microbiol."},{"key":"3020_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2055-6640(20)30322-8","volume":"3","author":"G Frattari","year":"2017","unstructured":"Frattari, G., Aagaard, L. & Denton, P. W. The role of miR-29a in HIV-1 replication and latency. J. Virus Erad. 3, 185\u2013191 (2017).","journal-title":"J. Virus Erad."},{"key":"3020_CR13","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.3389\/fmicb.2018.03185","volume":"9","author":"B Su","year":"2018","unstructured":"Su, B. et al. Potential application of MicroRNA profiling to the diagnosis and prognosis of HIV-1 infection. Front. Microbiol. 9, 3185 (2018).","journal-title":"Front. Microbiol."},{"key":"3020_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/2211536605666160829123118","volume":"5","author":"B Sun","year":"2016","unstructured":"Sun, B., Yang, R. & Mallardo, M. Roles of microRNAs in HIV-1 replication and latency. Microrna 5, 120\u2013123 (2016).","journal-title":"Microrna"},{"key":"3020_CR15","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nm1639","volume":"13","author":"J Huang","year":"2007","unstructured":"Huang, J. et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 13, 1241\u20131247 (2007).","journal-title":"Nat Med"},{"key":"3020_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-4690-1-43","volume":"1","author":"Y Bennasser","year":"2004","unstructured":"Bennasser, Y., Le, S. Y., Yeung, M. L. & Jeang, K. T. HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 1, 43 (2004).","journal-title":"Retrovirology"},{"key":"3020_CR17","doi-asserted-by":"publisher","first-page":"e0185677","DOI":"10.1371\/journal.pone.0185677","volume":"12","author":"M Sanchez-Del Cojo","year":"2017","unstructured":"Sanchez-Del Cojo, M. et al. Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells. PLoS ONE 12, e0185677 (2017).","journal-title":"PLoS ONE"},{"key":"3020_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1742-4690-1-44","volume":"1","author":"S Omoto","year":"2004","unstructured":"Omoto, S. et al. HIV-1 nef suppression by virally encoded microRNA. Retrovirology 1, 44 (2004).","journal-title":"Retrovirology"},{"key":"3020_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/imr.12074","volume":"254","author":"NH Tobin","year":"2013","unstructured":"Tobin, N. H. & Aldrovandi, G. M. Immunology of pediatric HIV infection. Immunol. Rev. 254, 143\u2013169 (2013).","journal-title":"Immunol. Rev."},{"key":"3020_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1128\/CVI.00565-15","volume":"23","author":"DR Martinez","year":"2016","unstructured":"Martinez, D. R., Permar, S. R. & Fouda, G. G. Contrasting adult and infant immune responses to HIV infection and vaccination. Clin. Vaccine Immunol. 23, 84\u201394 (2016).","journal-title":"Clin. Vaccine Immunol."},{"key":"3020_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11904-006-0003-4","volume":"3","author":"CT Tiemessen","year":"2006","unstructured":"Tiemessen, C. T. & Kuhn, L. Immune pathogenesis of pediatric HIV-1 infection. Curr. HIV\/AIDS Rep. 3, 13\u201319 (2006).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"3020_CR22","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.3389\/fmicb.2018.03185","volume":"9","author":"B Su","year":"2018","unstructured":"Su, B. et al. Potential application of MicroRNA profiling to the diagnosis and prognosis of HIV-1 infection. Front. Microbiol. 9, 3185 (2018).","journal-title":"Front. Microbiol."},{"key":"3020_CR23","doi-asserted-by":"crossref","unstructured":"Qi, Y., Hu, H., Guo, H., Xu, P., Shi, Z., Huan, X., Zhu, Z., Zhou, M., Cui, L. MicroRNA profiling in plasma of HIV-1 infected patients: potential markers of infection and immune status. J. Public Health Emerg. 1 (2017).","DOI":"10.21037\/jphe.2017.05.11"},{"key":"3020_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1742-4690-5-118","volume":"5","author":"L Houzet","year":"2008","unstructured":"Houzet, L. et al. MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 5, 118 (2008).","journal-title":"Retrovirology"},{"key":"3020_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"3020_CR26","doi-asserted-by":"publisher","first-page":"e0155245","DOI":"10.1371\/journal.pone.0155245","volume":"11","author":"L Egana-Gorrono","year":"2016","unstructured":"Egana-Gorrono, L. et al. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: relationship with antiviral immune response and disease progression. PLoS ONE 11, e0155245 (2016).","journal-title":"PLoS ONE"},{"key":"3020_CR27","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.celrep.2018.07.079","volume":"24","author":"LM Agosto","year":"2018","unstructured":"Agosto, L. M., Herring, M. B., Mothes, W. & Henderson, A. J. HIV-1-infected CD4+ T cells facilitate latent infection of resting CD4+ T cells through cell-cell contact. Cell Rep. 24, 2088\u20132100 (2018).","journal-title":"Cell Rep."},{"key":"3020_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1128\/JVI.05590-11","volume":"86","author":"SK Choudhary","year":"2012","unstructured":"Choudhary, S. K. et al. Latent HIV-1 infection of resting CD4(+) T cells in the humanized Rag2(-)\/(-) gammac(-)\/(-) mouse. J. Virol. 86, 114\u2013120 (2012).","journal-title":"J. Virol."},{"key":"3020_CR29","doi-asserted-by":"crossref","unstructured":"Fowler, L., Conceicao, V., Perera, SS., Gupta, P., Chew, CB., Dyer, WB., Saksena, NK. 2016 First evidence for the disease-stage, cell-type, and virus specificity of microRNAs during human immunodeficiency virus type-1 infection. Med Sci (Basel) 4.","DOI":"10.3390\/medsci4020010"},{"key":"3020_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/QAI.0000000000001070","volume":"73","author":"S Yahyaei","year":"2016","unstructured":"Yahyaei, S. et al. Identification of a specific miRNA profile in HIV-exposed seronegative individuals. J. Acquir. Immune Defic. Syndr. 73, 11\u201319 (2016).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"3020_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11262-014-1114-4","volume":"49","author":"L Zhang","year":"2014","unstructured":"Zhang, L. et al. miR-27a suppresses EV71 replication by directly targeting EGFR. Virus Genes 49, 373\u2013382 (2014).","journal-title":"Virus Genes"},{"key":"3020_CR32","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1128\/JVI.05065-11","volume":"86","author":"K Chiang","year":"2012","unstructured":"Chiang, K., Sung, T. L. & Rice, A. P. Regulation of cyclin T1 and HIV-1 replication by microRNAs in resting CD4+ T lymphocytes. J. Virol. 86, 3244\u20133252 (2012).","journal-title":"J. Virol."},{"key":"3020_CR33","doi-asserted-by":"publisher","first-page":"e106360","DOI":"10.1371\/journal.pone.0106360","volume":"9","author":"L Egana-Gorrono","year":"2014","unstructured":"Egana-Gorrono, L. et al. Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors. PLoS ONE 9, e106360 (2014).","journal-title":"PLoS ONE"},{"key":"3020_CR34","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/jmv.24586","volume":"88","author":"A Rosca","year":"2016","unstructured":"Rosca, A. et al. miR-29a associates with viro-immunological markers of HIV infection in treatment experienced patients. J. Med. Virol. 88, 2132\u20132137 (2016).","journal-title":"J. Med. Virol."},{"key":"3020_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/imr.12061","volume":"253","author":"LT Jeker","year":"2013","unstructured":"Jeker, L. T. & Bluestone, J. A. MicroRNA regulation of T-cell differentiation and function. Immunol. Rev. 253, 65\u201381 (2013).","journal-title":"Immunol. Rev."},{"key":"3020_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1742-4690-5-117","volume":"5","author":"JK Ahluwalia","year":"2008","unstructured":"Ahluwalia, J. K. et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5, 117 (2008).","journal-title":"Retrovirology"},{"key":"3020_CR37","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1038\/srep05915","volume":"4","author":"R Reynoso","year":"2014","unstructured":"Reynoso, R. et al. MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro. Sci. Rep. 4, 5915 (2014).","journal-title":"Sci. Rep."},{"key":"3020_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12977-014-0108-6","volume":"11","author":"P Patel","year":"2014","unstructured":"Patel, P. et al. The microRNA miR-29a is associated with human immunodeficiency virus latency. Retrovirology 11, 108 (2014).","journal-title":"Retrovirology"},{"key":"3020_CR39","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1182\/blood-2011-09-379503","volume":"119","author":"F Bignami","year":"2012","unstructured":"Bignami, F. et al. Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. Blood 119, 6259\u20136267 (2012).","journal-title":"Blood"},{"key":"3020_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-4690-9-5","volume":"9","author":"KW Witwer","year":"2012","unstructured":"Witwer, K. W., Watson, A. K., Blankson, J. N. & Clements, J. E. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 9, 5 (2012).","journal-title":"Retrovirology"},{"key":"3020_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1042\/BJ20150700","volume":"470","author":"R Kapoor","year":"2015","unstructured":"Kapoor, R. et al. The miRNA miR-34a enhances HIV-1 replication by targeting PNUTS\/PPP1R10, which negatively regulates HIV-1 transcriptional complex formation. Biochem. J. 470, 293\u2013302 (2015).","journal-title":"Biochem. J."},{"key":"3020_CR42","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1111\/jcmm.13219","volume":"21","author":"R Wang","year":"2017","unstructured":"Wang, R. et al. The highly pathogenic H5N1 influenza A virus down-regulated several cellular MicroRNAs which target viral genome. J. Cell Mol. Med. 21, 3076\u20133086 (2017).","journal-title":"J. Cell Mol. Med."},{"key":"3020_CR43","doi-asserted-by":"publisher","first-page":"31027","DOI":"10.1074\/jbc.M112.387670","volume":"287","author":"WA Buggele","year":"2012","unstructured":"Buggele, W. A., Johnson, K. E. & Horvath, C. M. Influenza A virus infection of human respiratory cells induces primary microRNA expression. J. Biol. Chem. 287, 31027\u201331040 (2012).","journal-title":"J. Biol. Chem."},{"key":"3020_CR44","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/infdis\/jit311","volume":"208","author":"V Jain","year":"2013","unstructured":"Jain, V. et al. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J. Infect Dis. 208, 1202\u20131211 (2013).","journal-title":"J. Infect Dis."},{"key":"3020_CR45","doi-asserted-by":"publisher","first-page":"e36157","DOI":"10.1371\/journal.pone.0036157","volume":"7","author":"X You","year":"2012","unstructured":"You, X., Zhang, Z., Fan, J., Cui, Z. & Zhang, X. E. Functionally orthologous viral and cellular microRNAs studied by a novel dual-fluorescent reporter system. PLoS ONE 7, e36157 (2012).","journal-title":"PLoS ONE"},{"key":"3020_CR46","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1038\/s41598-020-60073-8","volume":"10","author":"F Hernandez-Walias","year":"2020","unstructured":"Hernandez-Walias, F. et al. New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: Involvement of miR-192, IL-6, sCD14 and miR-144. Sci. Rep. 10, 2937 (2020).","journal-title":"Sci. Rep."},{"key":"3020_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-9378-9-41","volume":"9","author":"A Luzzi","year":"2014","unstructured":"Luzzi, A. et al. HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas. Infect. Agent. Cancer 9, 41 (2014).","journal-title":"Infect. Agent. Cancer"},{"key":"3020_CR48","doi-asserted-by":"crossref","unstructured":"Saulle, I., Yahyaei, S., Biasin, M., Garziano, M., Masetti, M., Berzi, A., Trabattoni, D., Lo Caputo, S., Mazzotta, F., Clerici, M. Plasma and PBMC miRNA Profile in sexually HIV-1 exposed seronegative individuals. International AIDS Society (IAS), Vancouver, Canada (2015)","DOI":"10.1097\/QAI.0000000000001070"},{"key":"3020_CR49","first-page":"1607","volume":"128","author":"L Farberov","year":"2015","unstructured":"Farberov, L. et al. MicroRNA-mediated regulation of p21 and TASK1 cellular restriction factors enhances HIV-1 infection. J. Cell Sci. 128, 1607\u20131616 (2015).","journal-title":"J. Cell Sci."},{"key":"3020_CR50","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/1471-2334-13-250","volume":"13","author":"K Duskova","year":"2013","unstructured":"Duskova, K. et al. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts. BMC Infect. Dis. 13, 250 (2013).","journal-title":"BMC Infect. Dis."},{"key":"3020_CR51","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1210\/jc.2015-3993","volume":"101","author":"M Torriani","year":"2016","unstructured":"Torriani, M. et al. Dysfunctional subcutaneous fat with reduced dicer and brown adipose tissue gene expression in HIV-infected patients. J. Clin. Endocrinol. Metab. 101, 1225\u20131234 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3020_CR52","doi-asserted-by":"crossref","unstructured":"Devadas, K., Biswas, S., Haleyurgirisetty, M., Ragupathy, V., Wang, X., Lee, S., Hewlett, I. Identification of host micro RNAs that differentiate HIV-1 and HIV-2 infection using genome expression profiling techniques. Viruses 8 (2016).","DOI":"10.3390\/v8050121"},{"key":"3020_CR53","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/jcp.25131","volume":"231","author":"F Kadri","year":"2016","unstructured":"Kadri, F. et al. Defining plasma MicroRNAs associated with cognitive impairment in HIV-infected patients. J. Cell Physiol. 231, 829\u2013836 (2016).","journal-title":"J. Cell Physiol."},{"key":"3020_CR54","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1097\/QAD.0b013e32834b95bf","volume":"25","author":"KW Witwer","year":"2011","unstructured":"Witwer, K. W., Sarbanes, S. L., Liu, J. & Clements, J. E. A plasma microRNA signature of acute lentiviral infection: Biomarkers of central nervous system disease. AIDS 25, 2057\u20132067 (2011).","journal-title":"AIDS"},{"key":"3020_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/hiv.12822","volume":"21","author":"J Sadri Nahand","year":"2020","unstructured":"Sadri Nahand, J. et al. MicroRNAs and exosomes: Key players in HIV pathogenesis. HIV Med. 21, 246\u2013278 (2020).","journal-title":"HIV Med."},{"key":"3020_CR56","doi-asserted-by":"publisher","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","volume":"10","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar, S. et al. HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 10, e1004078 (2014).","journal-title":"PLoS Pathog"},{"key":"3020_CR57","first-page":"101","volume":"20","author":"JA Aberg","year":"2012","unstructured":"Aberg, J. A. Aging, inflammation, and HIV infection. Top Antivir. Med. 20, 101\u2013105 (2012).","journal-title":"Top Antivir. Med."},{"key":"3020_CR58","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1089\/aid.2012.0367","volume":"29","author":"C Lucero","year":"2013","unstructured":"Lucero, C. et al. Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells\/mm(3). AIDS Res. Hum. Retroviruses 29, 1161\u20131167 (2013).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"3020_CR59","doi-asserted-by":"publisher","first-page":"434","DOI":"10.21037\/atm.2017.08.38","volume":"5","author":"JP Routy","year":"2017","unstructured":"Routy, J. P. & Mehraj, V. Very early antiretroviral therapy permits CD8 T cells to keep HIV reservoirs at bay. Ann. Transl. Med. 5, 434 (2017).","journal-title":"Ann. Transl. Med."},{"key":"3020_CR60","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/imr.12064","volume":"254","author":"EM Wilson","year":"2013","unstructured":"Wilson, E. M. & Sereti, I. Immune restoration after antiretroviral therapy: The pitfalls of hasty or incomplete repairs. Immunol. Rev. 254, 343\u2013354 (2013).","journal-title":"Immunol. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03020-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T17:52:34Z","timestamp":1670089954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03020-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["3020"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-03020-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,6]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23477"}}